Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher Plescia
Christopher Plescia
Biology
Immunology
Molecular biology
Cancer research
Histone H3
7
Papers
94
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity.
2020
Nature Communications
Daniel S. Leventhal
Anna Sokolovska
Ning Li
Christopher Plescia
Starsha Kolodziej
Carey W. Gallant
Rudy Christmas
Jian-Rong Gao
Michael J. James
Andres Abin-Fuentes
Munira Momin
Christopher G Bergeron
Adam P Fisher
Paul F. Miller
Kip A. West
Jose M. Lora
Show All
Source
Cite
Save
Citations (48)
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL
2017
Molecular Cancer Therapeutics
Dorothy Brach
Danielle Johnston-Blackwell
Allison Drew
Trupti Lingaraj
Vinny Motwani
Natalie Warholic
Igor Feldman
Christopher Plescia
Jesse J. Smith
Robert A. Copeland
Heike Keilhack
Elayne Chan-Penebre
Sarah K. Knutson
Scott Ribich
Alejandra Raimondi
Michael J. Thomenius
Show All
Source
Cite
Save
Citations (40)
Abstract B133: Chromatin flow cytometry based quantification of cell type specific alterations in histone methylation states resulting from in vitro and in vivo EZH2 inhibitor treatment
2015
Molecular Cancer Therapeutics
Christopher Plescia
Sarah K. Knutson
Natalie Warholic
Alice McDonald
Heike Keilhack
Jesse J. Smith
Robert A. Copeland
Stephen J. Blakemore
Show All
Source
Cite
Save
Citations (0)
Abstract B85: EZH2 plays a critical role in B-cell maturation and in non-Hodgkin's lymphoma: Interplay between EZH2 function and B-cell activation
2015
Molecular Cancer Therapeutics
Danielle Johnston
Dorothy Brach
Christopher Plescia
Alison Drew
Trupti Lingaraj
Natalie Warholic
Jesse J. Smith
Robert A. Copeland
Heike Keilhack
Elayne Penebre
Sarah K. Knutson
Scott Ribich
Michael J. Thomenius
Alejandra Raimondi
Show All
Source
Cite
Save
Citations (0)
Abstract C87: EZH2 inhibition leads to decreased proliferation in SMARCA4-deleted ovarian cancer cell lines
2015
Molecular Cancer Therapeutics
Sarah K. Knutson
Allison Drew
Christopher Plescia
Robert A. Copeland
Jesse J. Smith
Heike Keilhack
Scott Ribich
Show All
Source
Cite
Save
Citations (3)
1